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Abstract: Spondylocostal dysostosis (SCDO) is a rare heritable congenital condition, characterized
by multiple severe malformations of the vertebrae and ribs. Great advances were made in the last
decades at the clinical level, by identifying the genetic mutations underlying the different forms
of the disease. These were matched by extraordinary findings in the Developmental Biology field,
which elucidated the cellular and molecular mechanisms involved in embryo body segmentation into
the precursors of the axial skeleton. Of particular relevance was the discovery of the somitogenesis
molecular clock that controls the progression of somite boundary formation over time. An overview
of these concepts is presented, including the evidence obtained from animal models on the embryonic
origins of the mutant-dependent disease. Evidence of an environmental contribution to the severity
of the disease is discussed. Finally, a brief reference is made to emerging in vitro models of human
somitogenesis which are being employed to model the molecular and cellular events occurring in
SCDO. These represent great promise for understanding this and other human diseases and for the
development of more efficient therapeutic approaches.
Keywords: spondylocostal dysostosis; somitogenesis clock; somite formation; HES7; LFNG; DLL3;
MESP2; TBX6; RIPPLY2
1. Introduction
Biomedical research employs multiple scientific inquiry approaches, such as basic,
clinical, and translational research and great advances have been made in any one of these
fronts. The ultimate aim is to have such a clear understanding of the molecular and cellular
causes of the phenotypical and clinical manifestations of Human diseases, so that a success-
ful therapeutic solution or preventive strategy may be developed. Developmental Biology
has greatly contributed to understanding the pathophysiology of multiple congenital dis-
eases. Congenital malformations, defined as structural or functional abnormalities that
are present since birth, are globally responsible for 11% of newborn deaths [1]. These are
largely due to genetic causes; however, phenotypic variability also depends on epigenetic
components and environmental factors to which the individual is exposed during embryo
development [2]. Within congenital malformations, spinal dysplasias occur in about 1 in
5000 births [3] and spondylocostal dysostosis (SCDO), considered a rare genetic disease,
has an estimated incidence of 1 in every 40,000 births [4].
This work aims to reflect the current evidence regarding the embryonic etiology of
SCDO. Data obtained from clinical, genetic, and developmental biology studies are steadily
closing the gaps on the comprehension of this rare, albeit severe congenital disease. Initially,
a summary of the phenotypic and genetic characteristics of SCDO is presented. This is
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followed by the current knowledge on the embryonic processes leading to the formation of
the axial skeleton, with a special focus on the molecular mechanisms underlying somite
formation and the somitogenesis molecular clock. The contribution of animal models for
evidence of a causal relationship between mutations in the genes involved in somitogenesis
and the development of SCDO are presented. Finally, the newly emerging in vitro models
to study the human somitogenesis clock and SCDO onset are discussed.
2. Spondylocostal Dysostosis
The term Spondylocostal dysostosis (SCDO) includes an etiologically heterogeneous
group of heritable diseases characterized by congenital malformations of the axial skeleton
at the level of the vertebrae and ribs, with varying degrees of severity. In 1938, Saul Jarcho
and Paul M. Levin made the first description of what is currently classified as Type 2
SCDO [5]. For many years thereafter, the Jarcho-Levin Syndrome classification covered
any individual with congenital defects in vertebrae segmentation and rib abnormalities,
even if only remotely related to the syndrome originally described [6].
Phenotypically, SCDO patients are characterized by a compressed trunk that is dispropor-
tionately short relative to the individual’s total height, a short and rigid neck, and protrusion
of the abdomen, often accompanied by moderate and non-progressive scoliosis [6]. Typically,
segmentation defects occur in 10 contiguous vertebrae. Respiratory complications are among
the most common causes of morbidity and mortality in affected individuals; the restrictions
imposed by the deformation of the rib cage affect lung development and signs and symp-
toms such as tachypnea, fatigue or lung infections are often present as a result of pulmonary
hypoplasia [7] and abnormal chest compliance [8]. SCDO usually occurs in isolation, with
manifestation of abnormalities restricted to the spine and ribs [6]. A somewhat similar, albeit a
clinically and radiologically independent disease, is spondylothoracic dysostosis (STD), first
described by Lavy, Palmer, and Merritt in 1966 [4,9]. STD’s main distinguishing feature is a
shorter but symmetrical chest, with fused thoracic vertebrae, and overall-normal ribs that are
fused next to their vertebral origin acquiring a fan-like or crab-like configuration. STD is often
associated with early death from respiratory dysfunction or infection [4,8].
The diagnosis of SCDO is based on the clinic and the radiological images. Radiological
findings are diversified and include the involvement of several segments of the spine, espe-
cially in the thoracic region, which present butterfly-like vertebrae, fused hemivertebrae
or vertebrae, and also diverse alterations to rib morphology (Figure 1). These include rib
enlargement, fusion, bifurcation or even agenesis, causing asymmetries with incorrect rib
alignment and often with a reduction in the total number of ribs [7]. The identification of
the specific disease type is confirmed by genetic tests to identify mutant alleles in one of
the seven currently known genes responsible for the different types of SCDO [6].J. Dev. Biol. 2021, 9, x FOR PEER REVIEW 3 of 15  
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• DLL3 (Delta-like protein 3)—Type 1 SCDO (OMIM #277300). Type 1 SCDO is the 
most common form found in clinical practice and the majority of the affected 
individuals result from inbreeding unions [6]. DLL3 mutations identified in patients 
include insertions, frameshift, splicing, and nonsense mutations leading to 
premature truncation or protein function impairment [11,12]. Phenotypically, the 
mutation of this gene leads to moderate, non-progressive scoliosis and rarely 
requires surgical intervention to stabilize the spine. The affected individuals 
consistently show an irregular ossification pattern, with the vertebral bodies 
assuming a rounded or oval shape during childhood (“pebble beach sign”), evolving 
into irregular vertebral bodies and hemivertebrae as ossification is completed [6]; 
• MESP2 (Mesoderm posterior protein 2)—Type 2 SCDO (OMIM #608681). The 
pathogenic variant of this gene results in straight ribs with fewer fusion points and 
therefore, more regularly aligned when compared to other types. SCDO type 2 has 
been described in three families, one of them with consanguineous parents [6]. 
Reported MESP2 missense mutations introduce premature stop codons leading to 
protein truncation [13]. Other mutations thought to severely reduce protein levels 
due to nonsense-mediated mRNA decay, are found in cases of STD and are 
associated with more severe phenotypes [6,13]; 
• LFNG (Lunatic Fringe)—Type 3 SCDO (OMIM #609813). There are two reports of 
LFNG mutations associated with SCDO. The first documented individual presented 
a more severe shortening of the spine than that found in the other SCDO subtypes, 
with all vertebral bodies exhibiting severe segmentation defects. Rib anomalies were 
similar to those in SCDO type 1 and 2 [14,15]. An additional report was made of an 
individual carrying two distinct mutations in LFNG, with multiple vertebral defects 
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Genetics and Main Phenotypic Characteristics of SCDO Subtypes
SCDO is a genetic disease with an autosomal inheritance pattern that is predominantly
recessive [10]. The disease is most common in cases of consanguinity of the parents and is
associated with the transmission of pathological mutations in genes with a key role in the
formation of the axial skeleton during embryogenesis. The SCDO-associated genes known
to date and their associated SCDO subtypes are the following:
• DLL3 (Delta-like protein 3)—Type 1 SCDO (OMIM #277300). Type 1 SCDO is the most
common form found in clinical practice and the majority of the affected individuals
result from inbreeding unions [6]. DLL3 mutations identified in patients include inser-
tions, frameshift, splicing, and nonsense mutations leading to premature truncation or
protein function impairment [11,12]. Phenotypically, the mutation of this gene leads
to moderate, non-progressive scoliosis and rarely requires surgical intervention to
stabilize the spine. The affected individuals consistently show an irregular ossification
pattern, with the vertebral bodies assuming a rounded or oval shape during childhood
(“pebble beach sign”), evolving into irregular vertebral bodies and hemivertebrae as
ossification is completed [6];
• MESP2 (Mesoderm posterior protein 2)—Type 2 SCDO (OMIM #608681). The pathogenic
variant of this gene results in straight ribs with fewer fusion points and therefore, more
regularly aligned when compared to other types. SCDO type 2 has been described in
three families, one of them with consanguineous parents [6]. Reported MESP2 missense
mutations introduce premature stop codons leading to protein truncation [13]. Other
mutations thought to severely reduce protein levels due to nonsense-mediated mRNA
decay, are found in cases of STD and are associated with more severe phenotypes [6,13];
• LFNG (Lunatic Fringe)—Type 3 SCDO (OMIM #609813). There are two reports of
LFNG mutations associated with SCDO. The first documented individual presented
a more severe shortening of the spine than that found in the other SCDO subtypes,
with all vertebral bodies exhibiting severe segmentation defects. Rib anomalies were
similar to those in SCDO type 1 and 2 [14,15]. An additional report was made of an
individual carrying two distinct mutations in LFNG, with multiple vertebral defects
along the entire spine [16,17]. In both reported cases, the identified missense mutations
were found to impair Lfng enzymatic activity and/or subcellular localization [17].
Comparable vertebral malformations were described in individuals with mutations
in the SLC35A3 gene encoding the Golgi UDP-GlcNAc transporter [18] (required for
Lfng substrate availability), which further supports the importance of Lfng activity in
axial skeleton formation;
• HES7 (Hairy enhancer of split 7)—Type 4 SCDO (OMIM #613686). HES7 belongs to
the family of hairy-enhancer-of-split transcription factors and is specifically expressed
in the embryonic paraxial presomitic mesoderm (PSM) [19]. Mutations in HES7
were described in infants presenting a shortened spine, with segmentation defects
predominantly in the thoracic region and irregularly aligned, fused ribs [20,21]. The
identified missense mutations resulted in significant reduction of HES7 transcriptional
inhibitory activity and alterations to its heterodimerization potential [20,21]. In some
cases, neural tube closure defects were also present, although there is no evidence of a
direct association of the two conditions. Type 4 SCDO was described in three families,
one of which also had inbreeding [6];
• TBX6 (T-box transcription factor 6)—Type 5 SCDO (OMIM #122600). SCDO-associated
mutations in TBX6 were described in three generations of the same family, following
an autosomal dominant inheritance. The affected individuals, all male, had a mixture
of hemivertebrae and blocks of fused vertebral segments, moderate scoliosis affecting
the middle thoracic region, with little involvement of the ribs [22,23]. Multiple other
cases have also been reported and the underlying TBX6 mutations include 16p11.2
genomic deletions, as well as nonsense and frameshift mutations, some of which were
found to alter TBX6 subcellular localization and/or transcriptional activity [16,24,25];
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• RIPPLY2 (Protein ripply 2)—Type 6 SCDO (OMIM #616566). The first report of mu-
tations in this gene described two brothers who had vertebral segmentation defects
in cervical and thoracic regions, including hemivertebrae and butterfly vertebrae but
overall normal ribs, with marked cervical kyphosis and moderate thoracic scolio-
sis [6,26]. One of the reported mutations introduces a premature stop codon, with
consequent loss of transcriptional repressor activity; the other is a missense mutation
localized at a mRNA splice site, but its functional consequences have not yet been
elucidated [26]. Since then, RIPPLY2 mutations were described in several other in-
dividuals with vertebral defects, many times associated with additional congenital
malformations [27,28];
• DMRT2 (Doublesex And Mab-3 Related Transcription Factor 2; OMIM *604935). An
homozygous DMRT2 variant, predicted to lead to the absence of full length DMRT2
protein product due to loss of the start codon, was recently associated with a severe
form of a SCDO-like phenotype [29]. The newborn presented severe costovertebral
defects, with all ribs affected either in size or shape (missing, fused, bifid, and hy-
poplastic), particularly in the most distal part. The vertebrae were also malformed
(laminae intervertebral fusions and irregular ossification), despite the absence of clear
segmentation defects of the vertebral bodies.
Despite the growing knowledge of the clinical and genetic aspects associated with
SCDO, significant challenges still remain in understanding the underlying pathological
mechanisms. Developmental engineering is a promising area in terms of treatment strate-
gies for diseases related to embryonic development of the spine. Its success however
depends on the ever-growing knowledge of the disease’s embryonic etiology together with
the embryonic developmental processes affected [30].
3. Formation of the Spine during Embryogenesis
The human axial skeleton is an extraordinarily structured system that starts to form
early in embryo development. Soon after blastocyst implantation in the uterus, gastrulation
takes place giving rise to the three embryonic germ layers: ectoderm, mesoderm, and
endoderm. The PSM, located bilaterally to the axial neural tube, is then segmented into
round-shaped transient structures called somites. As new somite pairs are periodically
formed in the anterior region, new cells are added to the posterior PSM, allowing somitogen-
esis to progress simultaneously with axial extension (reviewed in [31,32]). Between the 20th
day and the 5th week of gestation, a total of 42 to 44 pairs of somites are formed, with each
pair of somites appearing every 5 h [33,34]. Temporal precision of somitogenesis is observed
in all vertebrates, with species-specific periodicities, such as 90 min in the chicken and 2 h
in the mouse embryo (reviewed in [31]). Later, somites will differentiate into vertebrae, ribs,
and the skeletal muscles that provide stability and movement to the axial skeleton.
3.1. The Somitogenesis Molecular Clock
The temporal and spatial precision of somitogenesis has long intrigued many scientists.
One of the first theoretical models to explain how this process is regulated—the Clock and
Wavefront model—proposed the existence of a molecular oscillator (Clock) that would
define the tempo of somite formation and of a Wavefront of cell differentiation, that
would set the position of each new somite boundary [35]. The experimental evidence of
such a molecular oscillator was provided 20 years later, when Palmeirim et al. described
hairy1 gene expression oscillations in the chicken PSM with the same periodicity as somite
formation, 90 min [36] (Figure 2). Since then, many genes with oscillatory expression in the
PSM were found in multiple vertebrate species, suggesting that this is a conserved feature
of vertebrate embryos [37]. Strikingly, the clock periodicity in each species is directly
coupled to the time required to form a pair of somites. This is 90 min for the chicken
embryo, 2 h in the mouse, and approximately 5 h in humans.
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Figure 2. The Molecular Clock and Signaling Gradients in temporal/spatial control of vertebrate somitogenesis. (A) Repre-
sentation of one oscillation of hairy1 gene expression (blue) in the presomitic mesoderm (PSM) of a 48h chicken embryo. A
cell in the PSM (red dot) undergoes a complete cycle of gene expression activation-repression-activation as a new somite is
formed in the anterior-most PSM. (B) Opposing gradients of retinoic acid (RA) and WNT/FGF signaling converge at the
determination front; rostrally, the PSM tissue is already committed to form somites.
The wavefront proposed in the Clock and Wavefront model [35] plays an important
role in the correct positioning of each new somite boundary in the anterior-end of the
PSM [38]. An anterior retinoic acid (RA) signaling gradient opposes posterior-derived
Fgf and Wnt gradients, establishing the so-called determination front, where PSM cells
become irreversibly committed to form a somite within the next 3–4 molecular clock
oscillations [38–40]. Posterior-to-anterior gradients of Wnt and Fgf signaling activity
maintain cells in an undifferentiated state in the posterior PSM. Overexpressing Fgf8 at
the level of the determination front leads to the formation of smaller somites, while if
Fgf signaling is inhibited, larger somites are formed [38]. Moreover, both Fgf and Wnt
signaling are crucial for embryo elongation, thus coupling the process of somitogenesis
with anterior-to-posterior elongation [41,42].
Somitogenesis clock gene expression oscillations are cell autonomous, maintained
by negative feedback loops (Figure 3) (reviewed in [23]). The sum of the temporal delays
involved in the process—from transcription, RNA splicing and decay, to protein translation
and degradation—is crucial for robust oscillations to occur with a defined rhythm [31].
The deletion of all introns in mouse Hes7, for example, abolished oscillatory expression
dynamics, causing sustained Hes7 expression in the PSM and severe vertebral defects [43].
Also, a reduction in the number of Hes7 introns led to accelerated oscillations and super-
numerary somites, further evidencing the importance of the temporal delays imposed by
mRNA splicing in periodic clock oscillations [44]. Another important feature is the mRNA
and protein degradation rates. Nitanda and collaborators (2014) showed that the 3′UTR of
clock mRNAs is a key defining feature for their expression patterns. By exchanging the
3′UTRs of Hes7 and Lfng, they found that the expression patterns obtained were dictated
by the 3′UTR sequence per se, and not the gene it originally belonged to [45]. 3′UTRs
are important to regulate the half-life of the respective mRNAs, partly because these re-
gions are targeted by microRNAs, which can affect both the period and amplitude of the
oscillations, or even lead to dampening and loss of the oscillatory dynamics [46,47]. The
clock proteins’ half-life also plays an important role in the maintenance of the oscillatory
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dynamics [48]. Hirata and collaborators (2004) showed that increasing Hes7 half-life from
~20 to ~30 min lead to progressive dampening and loss of oscillations and, consequently, to
somite segmentation defects [48]. Interestingly, it was recently shown that the differences
in cell-autonomous oscillation periods of the segmentation clock between species can be
explained by the difference in the kinetics of the biochemical reactions involved in the
different time delays, and not by the gene sequences themselves [49].
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neighbor cell, the Notch intracellular domain (NICD) translocates to the nucleus where it activates 
the transcription of HES7, LFNG and DLL3 [23]. Lfng and Dll3 act cooperatively to repress further 
NICD activation [50], while Hes7 acts to represses its own expression and that of Lfng [23]. 
At the tissue level, the molecular oscillator needs to be synchronized between neigh-
boring cells, in order to allow the correct number of cells to simultaneously differentiate 
into a new somite. Work performed in mouse and zebrafish embryos showed that Delta-
Notch signaling is required to couple oscillations between adjacent cells [51–53]. Addi-
tionally, oscillations of genes belonging to different signaling pathways need to be cou-
pled. In fact, many clock genes are components of the Fgf, Wnt, and Notch signaling path-
ways [54,55], evidencing that the somitogenesis molecular clock is a complex network of 
oscillators, connected to ensure proper morphogenesis. For example, activation of Hes7 
expression in the embryo tail bud is dependent on Fgf and not Notch signaling, which is 
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Fgf signaling modulators, such as the negative regulator Dusp4 [51]. Wnt signaling-de-
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Figure 3. Negative feedback loops underlie somitogenesis clock oscillations. The identified mutated genes in SCDO
are represented. Upon Notch receptor activation by a Delta ligand from a neighbor cell, the Notch intracellular domain
(NICD) translocates to the nucleus where it activates the transcription of HES7, LFNG and DLL3 [23]. Lfng and Dll3 act
cooperatively to repress further NICD activation [50], while Hes7 acts to represses its own expression and that of Lfng [23].
At the tissue level, the molecular oscillator needs to be synchronized between neigh-
boring cells, in order to allow the correct number of cells to simultaneously differentiate into
a new somite. Work performed in mouse and zebrafish embryos showed that Delta-Notch
signaling is required to couple oscillations between adjacent cells [51–53]. Additionally,
oscillations of genes belonging to different signaling pathways need to be coupled. In fact,
many clock genes are components of the Fgf, Wnt, and Notch signaling pathways [54,55],
evidencing that the somitogenesis molecular clock is a complex network of oscillators,
connected to ensure proper morphogenesis. For example, activation of Hes7 expression in
the embryo tail bud is dependent on Fgf and not Notch signaling, which is then required
to maintain Hes7 expression throughout the PSM. Hes7 in turn activates Fgf signaling
modulators, such as the negative regulator Dusp4 [51]. Wnt signaling-dependent Axin2
also oscillates in the posterior PSM, out-of-phase relative to Lfng and Hes7 [39]. The cou-
pling between Notch, Fgf, and Wnt signaling pathways in somitogenesis was beautifully
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evidenced by performing experiments with microfluidics devices, which showed that
when Notch is entrained, Wnt expression dynamics is altered accordingly [56]. This is
particularly important in the anterior PSM where the signaling pathways must converge to
the same phase for proper somite segmentation [56].
Embryo clock synchronization between the left and right PSMs is crucial to ensure
that somite segmentation occurs in a bilateral symmetric fashion. In zebrafish embryos
Terra/Dmrt2a was shown to be necessary to maintain symmetrical clock gene expression
patterns, as well as the same number of somites, in the left-right PSMs [57]. This role in
left-right patterning is not conserved in the mouse embryo, but Dmrt2 was found to be
indispensable for proper somite maturation [58] and formation of the vertebrae and ribs [59].
3.2. Somite Segmentation and Vertebrae Formation
PSM cells located posteriorly to the determination front are under the influence of high
levels of Wnt and Fgf signaling and express the paraxial mesoderm marker Tbx6 (Figure 4).
As the embryo elongates and cells in the anterior PSM leave the Fgf8 domain, Tbx6 and
Notch are able to activate Mesp2 expression, delimiting in the caudal boundary of the next
somite to be formed. Mesp2 plays a central role in the formation of the somitic boundary
(reviewed in [60]). Mesp2 activates Ripply2 expression, which then represses Tbx6 [60,61].
Mesp2 also activates EphA4 which in turn induces the expression of EphrinB2 rostrally, in
the caudal region of the somite-to-be. Here, EphrinB2 initiates a molecular cascade leading
to rearrangements in the extracellular matrix [62] and to a mesenchymal-to-epithelial
(MET) transition, culminating in somite boundary formation. EphA and EphrinB2 are then
restricted to the rostral and caudal portion of the somite, respectively, ensuring proper
somite polarity [63] (Figure 4).
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Figure 4. From somitogenesis clock oscillations to somite boundary formation. Periodic activation of Mesp2 at the rostral
PSM, where FGF signaling is greatly decreased, triggers a molecular cascade ultimately leading to the budding off of a new
somite. This is a simplified schematic representation, where the identified mutated genes in SCDO are highlighted.
As somitogenesis progresses, the newly formed epithelial somites will undergo mod-
ifications and differentiate into multiple structures. Initially, the medial-ventral portion
of the somite undergoes an epithelial-to-mesenchymal transition under the influence of
Shh signaling emanating from the notochord and neural tube floor plate. This is now the
sclerotome, containing the precursors of the vertebrae and ribs (Figure 5). The dorsal-
lateral portion of the so ite remains epithelial and expresses Pax3, under the influence
of Wnt signaling from the dorsal neural tube—the der omyotome. The latter then fur-
ther differentiates into the myotome, which will originate the axial musculature and the
dermatome, which will form the dermis of the back [32]. Pax3 activates Dmrt2/Terra ex-
pression in the dermomyotome [64], where it plays an imp rtant role in somite patterning
and myogenesis [59,64].
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The sclerotome undergoes a re-segmentation process essential for the final config-
uration of the vertebrae and all the structures of the spine. After re-segmentation, the
caudal segment of a sclerotome joins the rostral segment of the adjacent sclerotome to
form a vertebra. Due to this process, each segment of the adult axial skeleton is derived
from a caudal and rostral part of two consecutive somites instead of one somite. The
dermomyotome maintains the initial segmented configuration of the somites, allowing the
derived muscles to intercalate each skeletal segment. This is crucial for the mobility and
stability of the axial skeleton in humans. The most ventral portion of the sclerotome then
surrounds the notochord to give rise to the body of the vertebrae and the intervertebral
discs. The notochord gives rise to the nucleus pulposus of the intervertebral discs. The
vertebral arch originates from the sclerotome cells that surround the neural tube. The ribs
originate from the sclerotome cells located in the ventro-lateral region (Figure 5) [65,66].
4. Evidence for the Embryonic Origin of SCDO from Animal Models
As described in the previous sections, the genetic mutations identified in SCDO pa-
tients are in genes involved in the somitogenesis molecular clock—DLL3, LFNG, and
HES7—and in th formation of the somite bou daries—MESP2, TBX6, and RIPPLY2. Each
mutated gene is at the or gin of different types of SCDO (described above). An additional
ion in DMRT2 has been reported associated with a phenotype that could represent a
new ype of SCDO [29]. Clues to how mutations in these ge es lead to SCDO and other
congenital malformations arise from Developmental Biology studies, where the role of
these genes has been extens v ly studi d in the context of vertebrate emb yo body seg-
m ntation. Mutant mice xperimental models have greatly con ribu d to understanding
th role of specific gen s in this process (as described in the previous section) and allow
to study in further d tail the molecular mechanisms that drive the onset of axial skeleton
malformations. In fact, mice mutated in each one of the known ge es that drive SCDO
ostly recapitulate the phenotypes observed in Humans SCDO patients.
• The first Dll3 mouse mutants were generated in 1961, in a series of experiments using
X-rays to induce gene muta ions [67,68]. These mice, known as pudgy mice, presented
shortened tails, trunks, and exte sive axial sk leton malformations, similarly to what
ca be observed in patients with SCDO type 1. The skeleton defects were traced back
t somitogenesis, where these mutants presented irregularly shaped and missing
posterior somites, and somite formation was delayed [69]. The somitogenesis clock
oscillations were perturbed in these mutants, as ell the Mesp2 expression domains,
which most probably underlies the phenotypes observed [69,70];
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• Studies using Mesp2 mutant mice showed that it is essential for the formation of
boundaries between adjacent somites in the anterior PSM. These mutants present
defects in somite segmentation and rostral-caudal polarity, which ultimately lead to
severe skeletal malformations across the axis extension, including rib fusions and
abnormally shaped vertebrae and ribs [71]. The similarity between the skeletal defects
in Human SCDO type 2 caused by MESP2 homozygous mutation and in the mouse
embryo was further confirmed by three-dimensional computed tomography [72];
• In Lfng homozygous mutant mice, somitic boundaries are unclear, generating somites
that are irregular both in size and shape. Hes7 is overexpressed along the PSM instead of
presenting the typical dynamic patterns, although Notch signaling remained dynamic [73].
Dorsal-ventral somite patterning is also affected [74,75]. Consequently, the axial skeleton
of these animals presents severe malformations, including incompletely formed vertebrae
and vertebral and rib fusions. This homozygous mutation is usually deadly in the
neonatal period due to respiratory problems driven by rib cage abnormalities;
• Heterozygous Hes7 mutant mice show kinked tails in 43% of the animals. The homozy-
gous embryos presented severe defects of the axial skeleton, as found in type 4 SCDO.
They had shorter trunks and tails and the majority died shortly after birth, apparently
due to respiratory problems. Vertebrae and ribs were abnormally formed and verte-
bral bodies and neural arches were fused across the vertebral column [19]. Further
analysis showed that Hes7 homozygous mutations lead to loss of Notch-dependent
oscillatory expression of Lfng, NCID, and Nrarp. Interestingly, dynamic expression
patterns of genes belonging to Fgf and Wnt signaling were maintained [73];
• Homozygous Tbx6 mouse mutants lack somites [76]. This is essentially because Tbx6
is required for paraxial mesoderm specification. In these mutants, there is no PSM and
three neural tubes are formed instead. A careful analysis of the heterozygous mutants
however, unveiled mild defects in the axial skeleton at E14,5 [76]. Additionally,
heterozygous mutations of Tbx6 in rats can lead to skeletal malformations, including
lumbar vertebral distortion and abnormal number of vertebrae, which resembles the
autosomal dominant form of human SCDO type 5 [77];
• Ripply2 mutant embryos fail to form clear boundaries between somites, which also
present polarity abnormalities and the homozygous mice die shortly after birth [78].
These mutants present severe axial skeleton malformations, including fused arches
and pedicles. This phenotype is very similar to that found in Mesp2 mutants, possibly
because both genes are involved in the same process of somite boundary formation;
• In 2006, Seo and collaborators engineered a Dmrt2 knock-out mouse in order to
study the role of this gene during embryonic development. Homozygous mutants
showed kinked tails and respiratory distress due to malformations of the thoracic
cage [59]. Mutants had truncated ribs, rib bifurcations and fusions, along with other
vertebral defects. Dmrt2 mutant mice die perinatally, similarly to the reported case of
DMRT2-associated SCDO [59].
4.1. Environmental Contributions to SCDO
Besides the genetic background, the microenvironment experienced by the embryo
may influence major steps of development, such as the formation of the axial skeleton [2].
Somite formation is highly regulated both in time and space and can be severely impacted
by environmental factors. It has long been known that gestational hypoxia, for example,
can lead to axial skeletal malformations [2]. Sparrow and collaborators (2012) further
showed that gestational hypoxia combined with a pre-existing genetic risk for congenital
scoliosis, significantly increased the penetrance and severity of the vertebral defects [79].
In fact, they found that the mild segmentation defects observed in heterozygous Hes7+/−
and Mesp2+/− mutant mice, are severely exacerbated when the embryos experience short
periods of hypoxia during gestation. The authors further showed that this was mediated
by downregulation of Fgf8 expression in the PSM and consequent impairment of proper
somite formation [79]. Consistent with this finding, in high-altitude geographic regions
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where atmospheric oxygen concentrations are lower, patients with congenital scoliosis tend
to have a higher number and severity of rib deformities [80].
Besides external environmental factors, the health status and homeostasis of the
mother can also affect embryo development. For example, the probability of fetus malfor-
mations increases up to 4-fold in diabetic mothers, and birth defects can be so severe that
they lead to stillbirth [81]. Diabetes was recently validated as a risk factor for vertebral
defects [82]. Indeed, a case of SCDO was reported in a newborn from a diabetic mother,
along with other congenital malformations [83]. How elevated glucose levels in circulation
impact embryo axial skeleton formation is still unclear. However, it was recently shown
that the PSM presents a posterior-to-anterior gradient of glycolytic activity, which directly
regulates Fgf and Wnt signaling gradients [84]. It is possible that the excess of glucose in the
mother’s blood could affect this metabolic gradient, but this requires further investigation.
Further evidence that skeletal axis malformation could arise from a combination
of environmental factors with genetic predisposition has been provided by studies in
monozygotic twins. There are several reports of homozygous twins (identical genetic
information) that displayed skeletal defects at different axial levels, or even where only
one sibling presented vertebral defects [85–87]. This evidences the complex nature of the
etiology of congenital axial skeleton defects, including SCDO, where both genetic and
environmental factors are involved, many times in a synergistic manner.
4.2. New Insights on SCDO from Emerging Experimental Models
Although extraordinarily useful, animal models present important limitations when
addressing human congenital disorders. Despite common genes and processes involved in
the formation of equivalent morphological structures, there are species-specificities that
cannot be circumvented. This is the case when studying embryo somitogenesis and axial
skeleton formation, readily highlighted by the fact that the speed of somite formation
(and overall biochemical reactions) is significantly slower in humans, when compared
to mice or other animal model systems [49]. Additionally, although the same signaling
pathways are implicated in the somitogenesis clock in multiple species, there is limited
conservation of the specific genes that are involved [55]. The recent emergence of in vitro
gastruloid and PSM-like organoid model systems derived from human embryonic stem
cells or induced pluripotent stem cells have allowed the recapitulation of the initial stages
of human development, such as gastrulation or even somitogenesis, with increasing simi-
larity both at molecular and morphological levels [34,88,89]. Such systems were recently
employed to study the impact of SCDO-associated mutations on human somitogenesis
clock dynamics [34,88]. Two independent groups showed that a HES7 missense mutation,
previously reported in type 4 SCDO patients, completely abolishes HES7-driven gene
expression oscillations. Matsuda and collaborators further used induced pluripotent stem
(iPS) cell lines derived from different patients with SCDO clinical features. In both cases,
HES7 reporter activity showed sustained oscillations in 3D PSM-spheroids prepared from
these cells. Mutations underlying the SCDO phenotypes were found in MESP2 and DLL3
genes. In the latter case, although 2D cultures showed clock oscillations, in the 3D culture
system those were rapidly dampened, which is consistent with a requirement for Dll3 in
maintaining the synchrony between cells [88]. These reports highlight the potential of
these in vitro models to study the genetic mechanisms driving SCDO and the potential
contribution of environmental factors to the onset of human vertebral defects.
5. Conclusions
SCDO and other congenital axial skeleton disorders have compelled developmental
biologists towards a deeper understanding of how the axial skeleton is formed during
embryogenesis and, specifically, of the molecular and cellular events that are dysregulated
in these situations. This is a paradigmatic example of how clinical and basic research,
while pursuing fundamentally different approaches, can converge to better understand
and respond to human congenital diseases. It is now clear that mutations in key genes
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participating in the somitogenesis clock and in somite boundary formation may lead to
congenital malformations of the axial skeleton. However, much remains to be known about
how each mutation elicits its characteristic phenotype and how different environmental
factors may potentiate or even protect from more severe manifestations.
The current knowledge on the embryonic etiology of SCDO has greatly relied on the use
of animal embryo models, and then cautiously inferred to be similar in Humans, at least to
some extent. New emerging in vitro model systems are now allowing researchers to directly
address the molecular and cellular processes occurring in the human system, without the
technical and ethical constraints imposed on the use of human embryos. This opens the way
for foreseeable significant advances in biomedical research in the near future.
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